Cork to feel pharma merger ‘pain’

CORK will suffer “some pain” because of mergers and acquisitions in the pharmaceutical industry, according to IDA chief executive Barry O’Leary.

He said every single one of the multinationals that operate in Ireland has too many plants in its network, adding that the ones most at risk around the globe are in high-cost locations.

“If some of those are in Ireland, they will be under definite pressure and some of them are in Ireland,” he said.